Global Proteomics Conference

Dubai, UAE   October 12-13, 2017

Dubai, UAE October 12-13, 2017

Theme: Improved Understanding, Latest Advances And Future Prospects In The Field Of Proteomics

Greetings from Proteomics Meeting 2017!

Meetings International absolutely delighted to welcome you to the Global Proteomics Conference which will be held in Dubai, UAE on October 12-13, 2017. With a theme of “Improved Understanding, Latest Advances And Future Prospects In The Field Of Proteomics.”

Meetings International provides a Global Platform for Biochemistry Professionals, Biotech, Medical and Healthcare Professionals to Exchange Ideas, Knowledge and Networking at its 100+ International Conferences.

We are looking forward to provide you with a superb environment in global proteomics to present, discuss and advance your proteomic research. The world class scientific programme will consolidate existing knowledge while at the same time increase your awareness of leading edge and forward looking advances in the field. It also includes previous milestone developments in proteomics, the current state of the art as well as newly arising areas and opportunities and application of proteomics in clinical trials, therapeutic protein production and disease diagnosis, including opportunities for brainstorming and networking to provide solutions in global healthcare.

We look forward to seeing/welcoming you in Proteomics Meeting 2017 for an experience of a lifetime.

Meetings International proudly announces the Global Experts Meeting on Global Proteomics Conference scheduled during October 12-13, 2017 at Dubai, UAE. With a theme of “Improved Understanding, Latest Advances And Future Prospects In The Field Of Proteomics".

Meetings International provides a Global Platform for Chemistry Professionals, Biotech, Medical and Healthcare Professionals to Exchange Ideas, Knowledge and Networking at its 100+ International Conferences.

Proteomics market analysis has its advancement in case of Proteomics equipment’s & technologies this has made enormous progress in past few years, the global proteomics market is valued at USD 12.54 Billion in 2016. This market is expected to grow at a CAGR of 11.7% during the forecast period to reach USD 21.87 Billion by 2021. Proteomics  is a branch concerned with applying the techniques of molecular biology, biochemistry, and genetics to analysing the structure, function, and interactions of the proteins produced by the genes of a particular cell, tissue, or organism, with organizing the information in databases, and with applications of the data  compare genomics.

Proteomics Meeting 2017 conference will impact an attractive moment to meet people in the research field and therefore it takes a delight in opening a gate to meet the ability in the field, young researchers and potential speakers. The conference also includes essential topics on Protein Biochemistry, Proteomics Discovery & Function, Analytical Proteomics & Genomics, Proteomics for Bioinformatics, Cancer & Clinical proteomics, Protein Engineering & Molecular Design, Proteomics Technologies, Biomedical Sciences In Proteomics, Gene Expression Profiling, Epigenetics,Metabolomics, Genome Sequencing, Single Cell Genomics, Biostatistics & Systems biology and many more.

Attend to gain an unmatched experience in the Biochemistry field.

Meetings International Proteomics Meeting will offer you an unmatched attendee experience. In addition to the many scientific sessions and take-home case study examples, you will leave this event with many other novel development strategies from some of our workshops and symposiums. Engage in dynamic conversation with your industry peers at our multiple networking sessions, and takeaway novel drug development and commercialization strategies, which could speed up time to market and save your organization millions. We hope you will join us in Dubai ,UAE on October to enhance your research capabilities, and increase time to market on therapeutics.


Operating Committee

CEO and Founder

Meetings International PTE LTD.

Track 1: Protein Biochemistry

Proteins are a primary constituent of human bodies and one of the important molecules studied in biochemistry. Many of the proteins constitutes of enzymes or subunits of enzymes. Proteins also form struts and joints of the cytoskeleton. Each protein is linear polymers made up of amino acids. Protein complexes  are large biomolecules, or macromolecules, consisting long chains of amino acid residues. Proteins perform a variety of functions within organisms, including catalysing metabolic reactions, DNA replication, responding to stimuli, and transporting molecules from receptors to site of action. Proteins differ from one another primarily in their sequence of amino acids, which is monitored by the nucleotide sequence of their genes, resulting in protein folding into a specific active three-dimensional structure.

 Track 2: Proteomics Discovery & Function

Proteomics is the large number  study of proteins. The proteome is the entire set of proteins, produced or changed by an organism/system. This varies with time and distinct requirements, or stresses, that a cell or organism undergoes. Proteomics is an combining system that has increased greatly from the genetic information of the Human Genome Project, it is also emerging  into scientific research and exploration of proteomes from the intracellular protein composition, structure, and its own unique activity patterns. Proteomics is an important one of the functional genomics.

Track 3: Analytical Proteomics & Genomics

Proteomics are applied to identify   protein modification to determine the difference between a wild type and a genetically modified organism. It is also used to study protein-protein interactions involved in plant defence reactions. Genomics is the new science that deals with the identification of all the sequences in the entire genome and involves in the genetic make-up of organisms.The genome is a complete set of genes inside a cell. Genomics is the study of Genomic sequence is used to study the functions of the numerous genes such as functional genomics and to compare the genes in one organism with the another one i.e, comparative genomics, or to generate the 3-D structure of one or more proteins from each protein family, through this we can identify structural genomics. Analytical methods such as protein identification, analysis of protein primary structure and post-translational modifications by means of the most comprehensive technologies for proteomics, mass spectrometry and bioinformatics.

Track 4: Proteomics for Bioinformatics

Proteomics technologies are improving  and  new technologies are introduced in this method. Nowadays high improvement  of proteome data is possible. The new and rapidly emerging field of bioinformatics in proteomics is implementing new algorithms to handle more and heterogeneous data sets and to improve the knowledge of discovery process. New algorithms are implemented  for image analysis of two dimensional gels .And it have been developed and improved within the last five years. The mass spectrometry data analysis algorithms for peptide mass fingerprinting (PMF) and peptide fragmentation fingerprinting (PFF) have been developed . The local proteomics bioinformatics has become a platforms  to emerge as data management systems and also a knowledge bases in Proteomics. The recent developments in bioinformatics for proteomics with emphasis on expression proteomics.

Track 5: Cancer & Clinical proteomics

Cancer is an abnormal and uncontrolled division of cells which results in malignant growth or tumour. Although  there is an  improvement in the proteomic technologies ,it would largely contribute to diagnosis  cancer and treatment in the future, the technology most frequently used for the analysis of clinical tissue samples is the two-dimensional gel electrophoresis (2DE)  are combined with the matrix assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS).Proteomics identifies the information flow through the intercellular protein circuitry that communicates with the extracellular microenvironment and then ultimately to the serum/plasma macroenvironment and clinical utility of diagnostic patterns because of low molecular weight metabolites, peptides, and  also protein fragments  which may have higher accuracy than the  traditional biomarkers for the cancer detection. These diagnostic fragments may one day be harvested by circulating nanoparticles and designed to absorb, enrich, and amplify the repertoire of diagnostic biomarkers generated even at the critical, initial stages of carcinogenesis.

Track 6: Protein Engineering & Molecular Design

Protein engineering, the  process of developing the useful or valuable proteins.  In this protein engineering  there are more research taking place into the understanding of protein folding and recognition for the protein design principles. Development of the ability to design protein molecules will open a path to the fabrication of devices to complex atomic specifications. This process will involve in the construction of molecular machinery and  able to position reactive groups to atomic precision. It could lead to great advances in computational devices and  improvement  to change the biological materials. The existence of this path has implications for the present.

Track 7: Proteomics Technologies

The origin of proteomics technologies for global detection and quantitation of proteins creates new opportunities and challenges for those seeking to gain greater understanding of diseases. The high passing proteomics technologies are combining with the advanced bioinformatics and  are extensively used to identify  the molecular signatures of diseases based on protein pathways and signaling cascades.  The mass spectrometry plays a vital role in the  proteomics and has  to become an indispensable tool for  the molecular and cellular biology. While the potential is high, many challenges and issues are remain to be solved, such as mining low abundant proteins and integration of proteomics with genomics and metabolomics data. Even so, proteomics is the base for constructing and extracting useful knowledge to biomedical research.

Track 8: Biomedical Sciences In Proteomics

Biomedical research is  generally  known as medical research. And  it is the basic research, applied research, or translational research conducted to aid and supports the development of knowledge in the field of medicine.Proteomics is used in many areas of research such as discovery of markers for diagnosis and vaccine candidates, understanding pathogenic mechanisms, and also in the study of expression patterns at different time points and  also in response to different stimuli, and in elucidating the functional protein networks. Proteomics analysis involves  in the sample preparation, protein separation, and protein identification.

Track 9: Gene Expression Profiling

Expression profiling  is an application of proteomics , where proteins are identified at a certain time in an organism as a result of the expression to a stimulus. Proteomics are also used to develop a protein-network map where the  interaction among proteins can be determined for a particular living system.Gene expression profiling is the determination of the pattern of  the genes expressed, at the level of transcription and under specific circumstances or in a specific cell to give a global picture of cellular function.There are different techniques to measure the profiling it include DNA microarrays which measure the relative activity of previously identified target genes, or sequencing technologies that allow profiling of all active genes.

Track 10: Epigenetics

Epigenetics, the study of potentially heritable changes in  the gene expression (active versus inactive genes) and  that does not involve  the changes to the underlying DNA sequence - a change in phenotype without a change in genotype and which in turn affects how cells read the genes. Epigenetic change is a regular and natural occurrence but it can also be influenced by the  more  factors such as age, the environment/lifestyle, and  the disease state. Epigenetic modifications can  also manifest as commonly as the manner in which cells terminally differentiate to end up as skin cells, liver cells, brain cells, etc.   And also epigenetic change can have more damaging effects that can results in diseases like cancer. At least three systems including DNA methylation, histone modification and non-coding RNA (ncRNA) and associated gene silencing are currently considered to initiate and sustain epigenetic change. New and ongoing research is continuously uncovering the role of epigenetics in a variety of human disorders and fatal diseases.

Track 11: Metabolomics

Metabolomics ,it is the study of low molecular weight molecules or metabolites  are found within cells and biological systems.  The metabolome is a measure of the inputs and outputs of biological pathways and it is often considered to more representative of the functional state of a cell than other ‘omics measures such as genomics or proteomics.  In addition, many metabolites are conserved across the  various animal species, facilitating the extrapolation of research findings in  the laboratory animals to humans.  Common technologies  are used for measuring the metabolome include the  mass spectrometry (MS) and  also nuclear magnetic resonance spectroscopy (NMR), which can detect  the hundreds to thousands of unique chemical entities (UCE).

Track 12: Genome Sequencing

Genome sequencing is a technique to figuring out the order of DNA nucleotides, or bases, in a genome-the order of As, Cs, Gs, and Ts that make up an organism's DNA. New sequencing technologies are implemented , such as  the massive parallel sequencing have also opened up the prospect of personal genome sequencing as a diagnostic tool

Track 13: Single Cell Genomics

Single-cell genomics is advancing rapidly and it  is generating many new insights into complex biological systems, ranging from the diversity of microbial ecosystems to the genomics of human cancer. It focus on the technical challenges of making measurements that start from a single molecule of DNA, and then explore how some of these recent methodological advancements have enabled the discovery of unexpected new biology.  Methods for  the  genomic analysis at the  single-cell resolution enable the  new understanding of  the complex biological phenomena. Single-cell techniques are  ranging from flow cytometry and microfluidics to PCR and sequencing these are used to understand the cellular composition of complex tissues,  it helps to find new microbial species and perform genome-wide haplotyping.

Track 14: Biostatistics & Systems biology

Biostatistics is  an application of the statistics to a wide range of topics in biology. The science of biostatistics encompasses the design of biological experiments, especially in medicine, pharmacy and agriculture etc in this it includes the collection, summarization, and analysis of data from those experiments; and the interpretation of, and inference from, the results. A major branch of medical biostatistics, which is exclusively concerned with medicine and health. Systems biology is the computational and mathematical modeling of complex biological systems.  It is an prominent engineering approach applied to biological scientific research, systems biology is a biology-based inter-disciplinary field of study that focuses on complex interactions within biological systems, using a different approach to biological research.




 Proteomics Meeting 2017,

The global proteomics market is valued at USD 12.54 Billion in 2016. This market is expected to grow at a CAGR of 11.7% during the forecast period to reach USD 21.87 Billion by 2021. The global market exhibits potential for significant growth and is propelled by the increasing need for personalized medicine, R&D expenditure, technological advancements, and increased funding for proteomics projects. In this report, the global proteomics market is segmented on the basis of instrumentation technology, application, reagent, services & software, and region. On the basis of application, the market is segmented into drug discovery, clinical diagnostics, and other applications. The clinical diagnostics segment accounted for the largest share of the market in 2015. This is attributed to the increased understanding of the relevance of investigating and understanding patterns of protein expression for diseases and drug development.



The Asian proteomics market is driven by the increase in the number of diseases and the population suffering from these diseases. The market value of the proteomics market was $1.42 billion in 2012, and is expected to reach $4.16 billion by 2018, at a CAGR of 19.8%.



The large share in the global proteomics  attributed to presence of developed research infrastructure in the U.S. & Canada, increasing acceptance of personalized medicine, and growing adoption of technologically advanced products in this region. The Asia-Pacific region is expected to register the highest CAGR, due to the growth in research activities and increasing investments by leading players and respective government agencies in the region.

About Dubai :

Dubai is the most populous city in the United Arab Emirates (UAE). It is located on the southeast coast of the Persian Gulf and is one of the seven emirates that make up the country. The city of Dubai is located on the emirate's northern coastline and heads up the Dubai-Sharjah-Ajman metropolitan area. Dubai is to host World Expo 2020. It provides opportunities for global participation and robust development in the field of biochemistry and proteomics, global biotechnology and other related sectors as it strives to be the preferred destination for biotechnology and biochemistry investments. Dubai delivers a world class education and also immense job opportunities for well-educated students.

The global proteomics market was valued at nearly $5.1 billion in 2014 and the market was valued at over USD 11.8 billion in 2015. The  global market of proteomics compound annual growth rate (CAGR) of 18.0% to reach a forecast value of $11.6 billion by 2019.

The global protein-labeling market reached $2.2 billion in 2016. The market should reach $4.2 billion by 2021, growing at a compound annual growth rate (CAGR) of 14.1% from 2016 to 2021.

The global market for sample preparation in genomics, proteomics and epigenomics reached $5.2 billion in 2015. The market should reach $5.6 billion in 2016 and $7.7 billion by 2021, growing at a compound annual growth rate (CAGR) of 6.5% from 2016 to 2021.

Target Audience

  • Proteomics Instrumentation Technology Product Manufacturers
  • Researchers and Scientists
  • Proteomics Industry Consulting Firms
  • Proteomics Research and Development (R&D) Companies
  • Healthcare Institutions
  • Research Institutes
  • Market Research and Consulting Firms



Societies :

  •  The American Society for Biochemistry and Molecular Biology
  •  European Federation for Clinical Chemistry and Laboratory Medicine
  •  Japan Society of Clinical Chemistry (JSCC)
  •  Australian Society Biochemistry and Molecular Biology     
  •  Asia-Pacific Federation for Clinical Biochemistry and Laboratory Medicine(APFCB)
  •  Belgian Society of Biochemistry and Molecular Biology
  •  International Federation of Clinical Chemistry and Laboratory Medicine
  • Spanish Society for Clinical Biochemistry and Molecular Pathology
  •  The Malaysian Society for Biochemistry & Molecular Biology (MSBMB)
  •  The Malaysian Society for Molecular Biology and Biotechnology (MSMBB)
  •  Malaysian Association Of Clinical Biochemist

Associations :

  •  Human Proteome Organization
  • European Proteomics Association (Eupa)
  • Spanish Proteomics Society– (Seprot)
  • Netherlands Proteomic Platform (Npp)
  • Japan Human Proteome Organisation (Jhupo)
  • Italian Proteomic Association (Itpa)
  • Portugese Proteomic Association (Rede Procura)
  • Iranian Proteomic Society
  • Taiwan Proteomic Society (Tps)
  •  Austrian Proteomics Society
  •  European Proteomics Association
  • World Association for Chinese Biomedical Engineers
  • Chinese-American Chemical Society
  • The Hong Kong Medical Association
  • The Chinese Society of Biochemistry & Molecular Biology
  • Chinese Chemical Society
  • Chinese Society for Cell Biology
  • Genetics Society of China
  • Biochemical Society
  • Protein Biochemistry
  • Proteomics Discovery & Function
  • Analytical Proteomics & Genomics
  • Proteomics for Bioinformatics
  • Cancer & Clinical proteomics
  • Protein Engineering & Molecular Design
  • Proteomics Technologies
  • Biomedical Sciences In Proteomics
  • Gene Expression Profiling
  • Epigenetics
  • Metabolomics
  • Genome Sequencing
  • Single Cell Genomics
  • Biostatistics & Systems biology

2 Organizing Committee Members

Media Partners & Collaborations